SAU:4013's ROE % is ranked better than 92.64% of 625
companies
in the Healthcare Providers & Services industry
Industry Median: 5.84
vs SAU:4013: 30.63
Dr Sulaiman Al Habib Medical Services Group (SAU:4013) ROE % Explanation
ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.
The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:
Note:
The net income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net Income is used.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.
Dr Sulaiman Al Habib Medical Services Group ROE % Related Terms
Dr Sulaiman Al Habib Medical Services Group ROE % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dr Sulaiman Al Habib Medical Services Group ROE % Chart
Dr Sulaiman Al Habib Medical Services Group Annual Data
For the Medical Care Facilities subindustry, Dr Sulaiman Al Habib Medical Services Group's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dr Sulaiman Al Habib Medical Services Group ROE % vs Healthcare Providers & Services Industry
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
ROE % is displayed in the 30-year financial page.
Dr Sulaiman Al Habib Medical Services Group (SAU:4013) has a ROE % of 25.40% as of Mar. 2026. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Dr Sulaiman Al Habib Medical Services Group and its competitors. This is 14% below median its historical median of 29.43. Over the past decade, Dr Sulaiman Al Habib Medical Services Group's ROE % has ranged from 19.81 to 33.90. According to the industry distribution chart, Dr Sulaiman Al Habib Medical Services Group ranks #46 out of 625 companies in the Healthcare Providers & Services industry, placing it in the top 7.4%.
Is Dr Sulaiman Al Habib Medical Services Group's ROE % too high?
Dr Sulaiman Al Habib Medical Services Group's current ROE % of 25.40% is 14% below median its 10-year median of 29.43. Over the past 10 years, this metric has ranged from a low of 19.81 to a high of 33.90. The Healthcare Providers & Services industry median ROE % is 5.84. Dr Sulaiman Al Habib Medical Services Group's value of 25.40% is 334.9% above this industry median. Based on the distribution chart, Dr Sulaiman Al Habib Medical Services Group ranks #46 out of 625 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Dr Sulaiman Al Habib Medical Services Group has a GF Score™ of 92/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Dr Sulaiman Al Habib Medical Services Group's ROE % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Dr Sulaiman Al Habib Medical Services Group ranks #46 out of 625 companies for ROE %. This places Dr Sulaiman Al Habib Medical Services Group in the top 7% of its industry — outperforming the majority of peers. The industry median ROE % is 5.84. Dr Sulaiman Al Habib Medical Services Group's value of 25.40% is 334.9% above this benchmark. Historically, Dr Sulaiman Al Habib Medical Services Group's own ROE % has ranged from 19.81 to 33.90 over the past decade. While the company's 10-year median is 29.43 vs. the industry median of 5.84, Dr Sulaiman Al Habib Medical Services Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Healthcare Providers & Services company?
The median ROE % among Healthcare Providers & Services companies is 5.84, based on 625 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Dr Sulaiman Al Habib Medical Services Group's current ROE % of 25.40% is 334.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Dr Sulaiman Al Habib Medical Services Group and its competitors. For the Healthcare Providers & Services industry, the median ROE % is 5.84 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dr Sulaiman Al Habib Medical Services Group's current ROE % is 25.40%, which is 14% below median its own 10-year median of 29.43. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dr Sulaiman Al Habib Medical Services Group stock overvalued right now?
Based on GuruFocus' analysis, Dr Sulaiman Al Habib Medical Services Group (SAU:4013) is currently considered Significantly Undervalued. The stock's GF Value™ is ﷼396.06, compared to a current price of ﷼211.00 — trading 46.7% below its estimated fair value. The current ROE % is 25.40%, which is 14% below median its 10-year median of 29.43 and 334.9% above the Healthcare Providers & Services industry median of 5.84. Dr Sulaiman Al Habib Medical Services Group's overall GF Score™ is 92/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Dr Sulaiman Al Habib Medical Services Group (SAU:4013), the current ROE % is 25.40% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Dr Sulaiman Al Habib Medical Services Group (SAU:4013) Overvalued in 2026?
Based on GuruFocus' analysis, Dr Sulaiman Al Habib Medical Services Group stock appears to be undervalued.
The current stock price of ﷼211.00 is trading 46.7% below its estimated GF Value™ of ﷼396.06.
GuruFocus considers Dr Sulaiman Al Habib Medical Services Group to be Significantly Undervalued.
Key valuation signals for SAU:4013:
ROE %: 25.40% (14% below median its 10-year median of 29.43)
GF Value™: ﷼396.06 vs. price of ﷼211.00 (46.7% below fair value)
Industry Position: 334.9% above the Healthcare Providers & Services median (#46 of 625)
No single metric tells the full story. See the SAU:4013 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Dr Sulaiman Al Habib Medical Services Group Business Description
Dr Sulaiman Al Habib Medical Services Group provides private health and ancillary services in the Kingdom and the region through the establishment, management, and operation of hospitals, medical complexes, day surgery centers, pharmaceutical facilities, and other ancillary areas, including home health care, specialized laboratories, technology and information systems, facility maintenance, tele-medicine, revenue cycle management, medical equipment maintenance, and real estate activity. The company reports in three segments: Hospitals and Healthcare Facilities, Pharmacies, and HMG Solutions and Others. The majority of revenue comes from the Hospitals and Healthcare Facilities segment.
92GF Score
Get the complete analysis for SAU:4013
ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SAU:4013 has been successfully added to your 
